Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how one important protein falls under direct instructions from the body’s circadian clock and how this protein regulates fundamental circadian processes.